Posts filed under: Neurology & Neurovascular
BioSerenity, Inc., recently announced they received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Neuronaute® Electroencephalography (EEG) System and IceCap® EEG wearable device that allows physicians to remotely monitor patients with epilepsy. In general, EEG devices record the...
The novel coronavirus (COVID-19; SARS-CoV-2) pandemic has affected millions worldwide. There are still many unknowns surrounding this virus yet one thing is for sure, in serious cases the virus causes devastating effect on the body – and not just on...
NeuroPace RNS System for Epilepsy Received FDA Approval for MRI LabelingNeuroPace announced that its RNS® System has received FDA approval for MRI labeling, increasing number treatment options for approximately one million patients living with drug resistant focal epilepsy. Similar to...
Abbott‘s Low-Dose Neuromodulation Implant for Chronic Pain, Proclaim XR, was recently featured at 2020 International CES. Proclaim XR can connect to Apple products via Bluetooth and to enables patients to have more control over their treatment to regulate their pain...
Register to receive a free Global Neurological Devices Market Analysis, Size, and Trends Report synopsis and brochure. In a new submission to the FDA, Medtronic has presented its InterStim Micro neurostimulator and InterStim SureScan MRI leads into the neuromodulation device...
Register to receive a free U.S. Market Report Suite for Neurological Devices report synopsis and brochure While scientists have a variety of tools on hand to monitor and manipulate living brains, they still lack the ability to observe how large numbers of...
Register to receive a free U.S. Market Report Suite for Neurological Devices report synopsis and brochure Stryker recently launched the Surpass Evolve Flow Diverter following approval in March. Surpass Evolve is Stryker’s newest product release into the flow diversion space for the...
Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure NeuroCatch, Inc. has recently announced the approval of their NeuroCatch™ Platform for a medical device license as Canada’s first objective and rapid...
Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure A new approach to brain cancer treatment has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device designation, which denotes that...
Register to receive a free Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE Mark approval...
12
?Want more information about the market report mentioned in this article?
